• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Rises 100 Points; Crude Oil Rises Over 1%

    12/27/22 12:04:03 PM ET
    $ACER
    $ELYS
    $HTGM
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ACER alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Tuesday.

    The Dow traded up 0.32% to 33,309.30 while the NASDAQ fell 0.81% to 10,413.00. The S&P 500 also fell, dropping, 0.16% to 3,838.62.

    Check This Out: Top 5 Industrials Stocks That May Rally


    Leading and Lagging Sectors


    Energy shares rose by 0.8% on Tuesday. Meanwhile, top gainers in the sector included Mammoth Energy Services, Inc. (NASDAQ:TUSK), up 13%, and NextDecade Corporation (NASDAQ:NEXT), up 7%.


    In trading on Tuesday, consumer discretionary shares fell by 0.7%.


    Top Headline

     

    The S&P CoreLogic Case-Shiller 20-city home price index increased by 8.6% year-over-year in October, which is the least since October 2020.

     

    Equities Trading UP

     

    • KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) shares shot up 17% to $5.97. KalVista Pharmaceuticals reported a $58 million registered direct offering.
    • Shares of Elys Game Technology, Corp. (NASDAQ:ELYS) got a boost, shooting 120% to $0.3847. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) shares were also up, gaining 50% to $4.6399. HTG Molecular Diagnostics announced closing of a $10 million public offering.

     

    Equities Trading DOWN

    • Acer Therapeutics Inc. (NASDAQ:ACER) shares tumbled 23% to $2.8601. Acer Therapeutics and Relief Therapeutics reported the FDA approval of OLPRUVA for patients with urea cycle disorders.
    • Shares of Tuesday Morning Corporation (NASDAQ:TUEM) were down 46% to $0.83 after the company announced it will voluntarily delist from the Nasdaq Capital Market.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) was down, falling 58% to $0.1269. Pingtan Marine Enterprise announced receipt of Nasdaq notification letter.


    Also Check This Out: $5.5 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying


    Commodities

    In commodity news, oil traded up 1.2% to $80.54 while gold traded up 1.5% at $1,832.80.


    Silver traded up 1.7% to $24.315 on Tuesday while copper rose 2.3% to $3.8960.

     



    Euro zone


    European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.19%, London’s FTSE 100 rose 0.05% while Spain’s IBEX 35 Index rose 0.10%. The German DAX gained 0.48%, French CAC 40 rose 0.83% and Italy’s FTSE MIB Index fell 0.05%.

     


    Asia Pacific Markets


    Asian markets closed higher on Tuesday, with the Japan’s Nikkei gaining 0.16% and China’s Shanghai Composite Index rose 0.98%.


    Retail sales in Japan climbed 2.6% from a year earlier in November, while unemployment rate declined to 2.5% in November. Japanese housing starts fell by 1.4% year-over-year in November, missing market expectations for a 1.5% rise. China revised its GDP growth rate to 8.4% for 2021, compared to 8.1% previously, the National Bureau of Statistics said. Profits earned by Chinese industrial firms dropped on an annual basis by 3.6% to 7.7 trillion yuan during the January-November period.

     

    Economics

     

    • The US trade deficit in goods shrank by 15.6% from a month ago to $83.3 billion in November, recording the smallest gap since December 2020.
    • The S&P CoreLogic Case-Shiller 20-city home price index increased by 8.6% year-over-year in October, which is the least since October 2020.
    • The FHFA house price index came in unchanged from a month ago during October.
    • Wholesale inventories in the US increased by 1.0% month-over-month to $933.6 billion in November compared to a revised 0.6% growth in the previous month.

     

    Now Read This: This Analyst With 88% Accuracy Rate Boosts PT On Nike; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 102,247,570 cases with around 1,116,090 deaths. India confirmed a total of at least 44,678,540 cases and 530,690 deaths, while France reported over 39,159,750 COVID-19 cases with 161,150 deaths. In total, there were at least 662,415,920 cases of COVID-19 worldwide with more than 6,687,740 deaths.

    Get the next $ACER alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACER
    $ELYS
    $HTGM
    $KALV

    CompanyDatePrice TargetRatingAnalyst
    NextDecade Corporation
    $NEXT
    3/5/2026$7.00 → $6.00Hold
    TD Cowen
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    KalVista Pharmaceuticals Inc.
    $KALV
    1/9/2026$32.00 → $35.00Buy
    Needham
    KalVista Pharmaceuticals Inc.
    $KALV
    1/6/2026$28.00 → $32.00Buy
    Needham
    NextDecade Corporation
    $NEXT
    10/23/2025$8.00 → $7.00Hold
    TD Cowen
    NextDecade Corporation
    $NEXT
    9/15/2025$8.00Buy → Hold
    TD Cowen
    NextDecade Corporation
    $NEXT
    9/12/2025$10.00Overweight → Equal-Weight
    Morgan Stanley
    NextDecade Corporation
    $NEXT
    7/25/2025$15.00Buy
    Seaport Research Partners
    More analyst ratings

    $ACER
    $ELYS
    $HTGM
    $KALV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on NextDecade with a new price target

    TD Cowen reiterated coverage of NextDecade with a rating of Hold and set a new price target of $6.00 from $7.00 previously

    3/5/26 7:46:59 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Needham reiterated coverage on KalVista Pharmaceuticals with a new price target

    Needham reiterated coverage of KalVista Pharmaceuticals with a rating of Buy and set a new price target of $35.00 from $32.00 previously

    1/9/26 7:49:25 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

    Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Bethany Sensenig to its Board of Directors, effective April 15, 2026. Ms. Sensenig brings decades of leadership experience across the pharmaceutical and biotechnology industries, with deep expertise in finance, corporate strategy, and operations. "On behalf of the entire Board of Directors, it is a pleasure to welcome Bethany Sensenig, a highly accomplished industry leader," said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. "Her broad experience acro

    4/20/26 5:00:00 PM ET
    $ACOG
    $KALV
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mammoth Announces First-Quarter 2026 Conference Call

    OKLAHOMA CITY, April 20, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") will host a conference call on Monday, May 11, 2026, to discuss the Company's results for the first quarter ended March 31, 2026. The conference call will begin at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). Prior to the call, the Company will issue a press release announcing the results, which will also be available in the Investor Relations section of the Mammoth website.The call will be webcast live and can be accessed through the Company's website. Participants may also join by dialing +1-201-689-8433 and requesting the Mammoth conference call. Please log in or di

    4/20/26 8:00:00 AM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    NextDecade Announces Timing of First Quarter 2026 Investor Call

    NextDecade Corporation (‟NextDecade" or the ‟Company") (NASDAQ:NEXT) announced today that it will host a conference call and webcast on Friday, May 1, 2026, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to discuss developments from the first quarter of 2026. The Company expects to issue an accompanying press release and presentation that day before the market opens. The press release, presentation, and webcast may be accessed through the Company's website at https://investors.next-decade.com. A replay will also be available after the webcast concludes. About NextDecade Corporation NextDecade is committed to providing the world access to reliable, cleaner energy. We are focused

    4/13/26 4:30:00 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $ACER
    $ELYS
    $HTGM
    $KALV
    SEC Filings

    View All

    SEC Form DEF 14A filed by NextDecade Corporation

    DEF 14A - NextDecade Corp (0001612720) (Filer)

    4/23/26 5:17:57 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    SEC Form 8-K filed by NextDecade Corporation

    8-K - NextDecade Corp (0001612720) (Filer)

    4/15/26 4:29:22 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    SEC Form 10-KT filed by KalVista Pharmaceuticals Inc.

    10-KT - KalVista Pharmaceuticals, Inc. (0001348911) (Filer)

    3/25/26 4:35:23 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Director Amron Arthur H bought $18,900 worth of shares (10,000 units at $1.89), increasing direct ownership by 21% to 57,135 units (SEC Form 4)

    4 - MAMMOTH ENERGY SERVICES, INC. (0001679268) (Issuer)

    12/15/25 5:04:40 PM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $ACER
    $ELYS
    $HTGM
    $KALV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Audhya Paul K.

    4 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)

    4/20/26 7:42:17 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Sweeny Nicole

    4 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)

    4/20/26 7:41:40 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Piekos Brian

    4 - KalVista Pharmaceuticals, Inc. (0001348911) (Issuer)

    4/20/26 7:40:54 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OLPRUVA issued to ACER THERAPEUTICS INC

    Submission status for ACER THERAPEUTICS INC's drug OLPRUVA (ORIG-1) with active ingredient SODIUM PHENYLBUTYRATE has changed to 'Approval' on 12/22/2022. Application Category: NDA, Application Number: 214860, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/23/22 1:58:04 PM ET
    $ACER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    Financials

    Live finance-specific insights

    View All

    Mammoth Announces First-Quarter 2026 Conference Call

    OKLAHOMA CITY, April 20, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") will host a conference call on Monday, May 11, 2026, to discuss the Company's results for the first quarter ended March 31, 2026. The conference call will begin at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). Prior to the call, the Company will issue a press release announcing the results, which will also be available in the Investor Relations section of the Mammoth website.The call will be webcast live and can be accessed through the Company's website. Participants may also join by dialing +1-201-689-8433 and requesting the Mammoth conference call. Please log in or di

    4/20/26 8:00:00 AM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    NextDecade Announces Timing of First Quarter 2026 Investor Call

    NextDecade Corporation (‟NextDecade" or the ‟Company") (NASDAQ:NEXT) announced today that it will host a conference call and webcast on Friday, May 1, 2026, at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) to discuss developments from the first quarter of 2026. The Company expects to issue an accompanying press release and presentation that day before the market opens. The press release, presentation, and webcast may be accessed through the Company's website at https://investors.next-decade.com. A replay will also be available after the webcast concludes. About NextDecade Corporation NextDecade is committed to providing the world access to reliable, cleaner energy. We are focused

    4/13/26 4:30:00 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

    $49.1 million global net product revenue of EKTERLY® (sebetralstat) for the eight months ended December 31, 2025 1,702 patient start forms received in the US from launch through end of February, reflecting continued rapid adoption of first and only oral on-demand treatment for hereditary angioedema (HAE) EKTERLY launched in Japan by partner Kaken Pharmaceutical Co., LTD Company to host conference call today at 8:30am ET KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), today reported financial results for the eight months ended December 31, 2025, and provided a corporate update. As previously announced, the Company changed its fiscal year from ending April 30 of each year to ending Dece

    3/25/26 7:00:00 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    Leadership Updates

    Live Leadership Updates

    View All

    Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

    Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Bethany Sensenig to its Board of Directors, effective April 15, 2026. Ms. Sensenig brings decades of leadership experience across the pharmaceutical and biotechnology industries, with deep expertise in finance, corporate strategy, and operations. "On behalf of the entire Board of Directors, it is a pleasure to welcome Bethany Sensenig, a highly accomplished industry leader," said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. "Her broad experience acro

    4/20/26 5:00:00 PM ET
    $ACOG
    $KALV
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NextDecade Announces Chief Financial Officer Transition

    NextDecade Corporation (NextDecade or the Company) (NASDAQ:NEXT) announced today that Brent Wahl, Chief Financial Officer, has resigned from the Company effective October 20, 2025, and the Company has appointed Mike Mott, Senior Vice President Enterprise Transformation, as Interim Chief Financial Officer effective October 20, 2025. Mr. Wahl is leaving NextDecade to join a digital infrastructure company, and he has agreed to serve in a consultant capacity through December 31, 2025, to facilitate a seamless transition. The Company will initiate a comprehensive search process to find a permanent successor. "I want to thank Brent for the significant impact he has made at NextDecade," said M

    10/8/25 8:00:00 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

    KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. "I am pleased to welcome Bilal and Linea to our leadership team as we advance the global launch of EKTERLY," said Ben Palleiko, Chief Executive Officer of KalVista. "Their respective expertise in operations and human resources will be instrumental as we deliver on our commitment to people living with HAE." "I am excited to join KalVista and collaborate with such a talented team," said Mr. Arif. "This is a pivotal time for EKTERLY, and I am focused on strengthening the operational framework to ensure pe

    10/6/25 7:00:00 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ELYS
    $HTGM
    $KALV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by KalVista Pharmaceuticals Inc.

    SC 13G/A - KalVista Pharmaceuticals, Inc. (0001348911) (Subject)

    11/14/24 4:00:06 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by KalVista Pharmaceuticals Inc.

    SC 13G/A - KalVista Pharmaceuticals, Inc. (0001348911) (Subject)

    11/14/24 3:57:49 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by KalVista Pharmaceuticals Inc.

    SC 13G - KalVista Pharmaceuticals, Inc. (0001348911) (Subject)

    11/14/24 12:02:33 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care